Ricerca

Pubblicazioni IRIS

• Partial Inhibition Of Nampt Restores Metabolic Vulnerability And Synergizes With Anti-Myeloma Agents In Multiple Myeloma
  Anno: 2026
• CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma
  Anno: 2025
• Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysis
  Anno: 2024